BioPharma Resources

Drugs by condition

Drugs approved for anxiety disorders

Brand-name prescription drugs and biologics whose FDA label lists anxiety disorders as an approved use. Matched on the label phrases: "generalized anxiety disorder", "panic disorder", "anxiety".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

23

Still marketed, NDA or BLA

Drug classes

3

Novel drugs

8

New molecular entities and new biologics

In development

19

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for anxiety disorders.

All approved drugs for anxiety disorders, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 274 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Benzodiazepine (7)

  • Xanax Alprazolam · Upjohn · 1981
  • Ativan Lorazepam · Bausch · 1977
  • Klonopin Clonazepam · Cheplapharm · 1975
  • Valium Diazepam · Waylis Therap · 1963
  • Loreev Xr Lorazepam · Almatica · 2021
  • Xanax Xr Alprazolam · Upjohn · 2003
  • Ativan Lorazepam · Hikma · 1980

Monoamine Oxidase Inhibitor (1)

  • Marplan Isocarboxazid · Lifsa Drugs · 1959

Class not listed in FDA's data (15)

  • Paxil Paroxetine Hydrochloride · Apotex · 1992
  • Zoloft Sertraline Hydrochloride · Viatris · 1991
  • Nardil Phenelzine Sulfate · Parke Davis · 1961
  • Duloxetine Hydrochloride Duloxetine Hydrochloride · Almatica · 2026
  • Escitalopram Escitalopram Oxalate · Almatica · 2025
  • Venlafaxine Besylate Venlafaxine Besylate · Almatica · 2022
  • Drizalma Sprinkle Duloxetine Hydrochloride · Sun Pharm · 2019
  • Brisdelle Paroxetine Mesylate · Legacy · 2013
  • Beyaz Drospirenone, Ethinyl Estradiol, Levomefolate Calcium · Bayer Hlthcare · 2010
  • Venlafaxine Hydrochloride Venlafaxine Hydrochloride · Osmotica Pharm US · 2008
  • Yaz Drospirenone, Ethinyl Estradiol · Bayer Hlthcare · 2006
  • Lexapro Escitalopram Oxalate · Abbvie · 2002
  • Zoloft Sertraline Hydrochloride · Viatris · 1999
  • Paxil Cr Paroxetine Hydrochloride · Apotex · 1999
  • Effexor Xr Venlafaxine Hydrochloride · Upjohn · 1997

Drugs in development for anxiety disorders

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • SEP-363856UlotarontPhase 37 trials

    Otsuka · Generalized Anxiety Disorder, Schizophrenia, Major Depressive Disorder

  • ITI-1284JNJ-99245354Phase 36 trials

    Intra-Cellular Therapies, Inc. · Generalized Anxiety Disorder, Agitation Associated With Alzheimer's Dementia, Psychotic Disorders

  • DT120MM120, lysergide tartratePhase 34 trials

    Definium Therapeutics US, Inc. · Generalized Anxiety Disorder, Major Depressive Disorder

  • BuagafuranPhase 32 trials

    Beijing Union Pharmaceutical Factory Ltd · Generalized Anxiety Disorder

  • Buagafuran mimicPhase 32 trials

    Beijing Union Pharmaceutical Factory Ltd · Generalized Anxiety Disorder

  • FasedienolPhase 32 trials

    VistaGen Therapeutics, Inc. · Social Anxiety Disorder, Social Anxiety Disorder (SAD)

  • BNC210Phase 31 trial

    Bionomics Limited · Social Anxiety Disorder

  • Luye Pharma Group Ltd. · Generalized Anxiety Disorder

  • VQW-765Phase 31 trial

    Vanda Pharmaceuticals · Social Anxiety Disorder (SAD)

  • ONO-1110Phase 25 trials

    Ono Pharmaceutical Co., Ltd. · Fibromyalgia, Social Anxiety Disorder (SAD), Major Depressive Disorder (MDD

  • ABBV-932Phase 23 trials

    AbbVie · Bipolar I or II Disorder, Generalized Anxiety Disorder (GAD), Bipolar I Disorder

  • ENX-102ENX-102 -dose, ENX-102 mid-dosePhase 23 trials

    Engrail Therapeutics INC · General Anxiety Disorder, Social Anxiety Disorder (SAD), Generalized Anxiety Disorder

  • RE104Phase 23 trials

    Reunion Neuroscience Inc · Adjustment Disorder, Generalized Anxiety Disorder, Postpartum Depression

  • AFA-281Phase 22 trials

    Afasci Inc · Alcohol Abuse, Alcohol Abuse/addiction, Anxiety

  • CYB004Phase 21 trial

    Cybin IRL Limited · Generalized Anxiety Disorder

  • EMP-01Phase 21 trial

    atai Therapeutics, Inc. · Social Anxiety Disorder

  • NTX-1472Phase 21 trial

    Newleos Therapeutics, Inc. · Social Anxiety Disorder (SAD)

  • RGH-202Phase 21 trial

    Gedeon Richter Plc. · Social Anxiety Disorder

  • SYT-510Phase 21 trial

    Synendos Therapeutics AG · Generalized Anxiety Disorder

2 discontinued brand-name drugs whose label still names it

More on anxiety disorders: recruiting trials · published research

Related in psychiatry: Depression (major depressive disorder) · Schizophrenia · Bipolar disorder · ADHD · Insomnia · Opioid use disorder · Alcohol dependence · Smoking cessation · PTSD · Postpartum depression

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.